Clinical Trial

Trial Protocol ID USOR 24018_BO45217 *STAR*

Trial Description

A phase 3 randomized, open-label, multicenter study evaluating the efficacy and safety of divarasib versus sotorasib or adagrasib in patients with previously treated KRAS G12C-positive advanced or metastatic Non-Small Cell Lung Cancer 

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Roche

ClinicalTrials.gov NCT ID

  • NCT06497556